Decision: Favourable
Study Title:
A 52-week, randomised, double-blind, placebo-controlled, parallel group, multi-centre study of the efficacy and safety of GSK3511294 adjunctive therapy in adult and adolescent participants with severe uncontrolled asthma with an eosinophilic phenotype
NREC Code:
21-NREC-CT-171
Decision:
Favourable
Meeting Date:
08/12/2021
Study Type:
CT application
Principal Investigator:
Dr Desmond Michael Murphy
PI Institution:
Cork University Hospital
Sponsor:
IQVIA on behalf of GlaxoSmithKline Research & Development Limited